CA
Crewe Advisors Portfolio holdings
AUM
$707M
1-Year Return
14.7%
This Quarter Return
-0.03%
1 Year Return
+14.7%
3 Year Return
+67.44%
5 Year Return
+91.49%
10 Year Return
–
AUM
$725M
AUM Growth
-$137M
(-16%)
Cap. Flow
-$122M
Cap. Flow
% of AUM
-16.76%
Top 10 Holdings %
Top 10 Hldgs %
58.89%
Holding
818
New
105
Increased
85
Reduced
237
Closed
172
Top Buys
| 1 |
NVIDIA
NVDA
|
$26.5M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
$20.2M |
| 3 |
PGIM Ultra Short Bond ETF
PULS
|
$15.9M |
| 4 |
PACS Group
PACS
|
$14.6M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$9.47M |
Top Sells
| 1 |
The Ensign Group
ENSG
|
$145M |
| 2 |
Vanguard Total Bond Market
BND
|
$35.1M |
| 3 |
Pennant Group
PNTG
|
$19.3M |
| 4 |
Tesla
TSLA
|
$2.44M |
| 5 |
Capital Group Core Equity ETF
CGUS
|
$2.13M |
Sector Composition
| 1 | Financials | 8.29% |
| 2 | Technology | 5.05% |
| 3 | Consumer Discretionary | 3.18% |
| 4 | Healthcare | 3.1% |
| 5 | Industrials | 1.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Main BuyWrite ETF
BUYW
$815M
| $335 | ﹤0.01% |
+24
| New | +$335 |
|
602
Rocket Lab Corporation Common Stock
RKLB
$22.1B
| $332 | ﹤0.01% |
+13
| New | +$332 |
|
603
Brunswick
BC
$4.35B
| $324 | ﹤0.01% |
+5
| New | +$324 |
|
604
SPDR Portfolio Europe ETF
SPEU
$691M
| $324 | ﹤0.01% |
8
+5
| +167% | +$203 |
|
605
Sweetgreen
SG
$1.06B
| $321 | ﹤0.01% |
10
| – | – |
|
606
Johnson Controls International
JCI
$69.5B
| $316 | ﹤0.01% |
4
-145
| -97% | -$11.5K |
|
607
TPG
TPG
$8.64B
| $315 | ﹤0.01% |
5
+3
| +150% | +$189 |
|
608
PACCAR
PCAR
$52B
| $313 | ﹤0.01% |
3
-61
| -95% | -$6.36K |
|
609
Silgan Holdings
SLGN
$4.83B
| $313 | ﹤0.01% |
+6
| New | +$313 |
|
610
Textron
TXT
$14.5B
| $306 | ﹤0.01% |
4
-59
| -94% | -$4.51K |
|
611
Quest Diagnostics
DGX
$20.5B
| $302 | ﹤0.01% |
2
-28
| -93% | -$4.23K |
|
612
Acuity Brands
AYI
$10.4B
| $293 | ﹤0.01% |
+1
| New | +$293 |
|
613
Hologic
HOLX
$14.8B
| $289 | ﹤0.01% |
4
-114
| -97% | -$8.24K |
|
614
Thor Industries
THO
$5.94B
| $288 | ﹤0.01% |
+3
| New | +$288 |
|
615
Ashland
ASH
$2.51B
| $286 | ﹤0.01% |
+4
| New | +$286 |
|
616
Builders FirstSource
BLDR
$16.5B
| $286 | ﹤0.01% |
+2
| New | +$286 |
|
617
Ovintiv
OVV
$10.6B
| $284 | ﹤0.01% |
+7
| New | +$284 |
|
618
Invesco
IVZ
$9.81B
| $280 | ﹤0.01% |
+16
| New | +$280 |
|
619
Innoviva
INVA
$1.29B
| $278 | ﹤0.01% |
+16
| New | +$278 |
|
620
Neurocrine Biosciences
NBIX
$14.3B
| $273 | ﹤0.01% |
+2
| New | +$273 |
|
621
W.P. Carey
WPC
$14.9B
| $273 | ﹤0.01% |
+5
| New | +$273 |
|
622
DraftKings
DKNG
$23.1B
| $261 | ﹤0.01% |
+7
| New | +$261 |
|
623
Best Buy
BBY
$16.1B
| $258 | ﹤0.01% |
+3
| New | +$258 |
|
624
Graco
GGG
$14.2B
| $253 | ﹤0.01% |
+3
| New | +$253 |
|
625
Wallbox
WBX
$67.2M
| $251 | ﹤0.01% |
25
| – | – |
|